1. Home
  2. XTNT vs DMA Comparison

XTNT vs DMA Comparison

Compare XTNT & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.41

Market Cap

61.7M

Sector

Health Care

ML Signal

N/A

Logo Destra Multi-Alternative Fund

DMA

Destra Multi-Alternative Fund

N/A

Current Price

$7.64

Market Cap

66.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XTNT
DMA
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
61.7M
66.5M
IPO Year
2009
2011

Fundamental Metrics

Financial Performance
Metric
XTNT
DMA
Price
$0.41
$7.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
234.2K
23.9K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$53,337,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$6.94
52 Week High
$0.95
$9.15

Technical Indicators

Market Signals
Indicator
XTNT
DMA
Relative Strength Index (RSI) 44.91 50.88
Support Level $0.27 $7.44
Resistance Level $0.47 $7.76
Average True Range (ATR) 0.03 0.11
MACD 0.00 -0.00
Stochastic Oscillator 50.25 46.15

Price Performance

Historical Comparison
XTNT
DMA

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income, with an emphasis on income generation. The Fund pursues its investment objective by investing mainly in the income-producing securities of real estate investment trusts (REITs) and alternative investment funds, as well as common stocks and structured notes, bonds, and asset-backed securities.

Share on Social Networks: